| Title | Author(s) | Year | View Count |
 | Comment on "seroevidence for H5N1 influenza infections in humans: Meta-analysis" | Van Kerkhove, MD; Riley, S; Lipsitch, M; Guan, Y; Monto, AS; Webster, RG; Zambon, M; Nicoll, A; Peiris, JSM; Ferguson, NM | 2012 | 61 |
| Research findings from nonpharmaceutical intervention studies for pandemic influenza and current gaps in the research | Aiello, AE; Coulborn, RM; Aragon, TJ; Baker, MG; Burrus, BB; Cowling, BJ; Duncan, A; Enanoria, W; Fabian, MP; Ferng, Yh; Larson, EL; Leung, GM; Markel, H; Milton, DK; Monto, AS; Morse, SS; Navarro, JA; Park, SY; Priest, P; Stebbins, S; Stern, AM; Uddin, M; Wetterhall, SF; Vukotich Jr, CJ | 2010 | 62 |
| Findings, gaps, and future direction for research in nonpharmaceutical interventions for pandemic influenza. | Vukotich Jr, CJ; Coulborn, RM; Aragon, TJ; Baker, MG; Burrus, BB; Aiello, AE; Cowling, BJ; Duncan, A; Enanoria, W; Fabian, MP; Ferng, YH; Larson, EL; Leung, GM; Markel, H; Milton, DK; Monto, AS; Morse, SS; Navarro, JA; Park, SY; Priest, P; Stebbins, S; Stern, AM; Uddin, M; Wetterhall, SF | 2010 | 45 |
| Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses | Yen, HL; Hoffmann, E; Taylor, G; Scholtissek, C; Monto, AS; Webster, RG; Govorkova, EA | 2006 | 28 |
| Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice | Yen, HL; Monto, AS; Webster, RG; Govorkova, EA | 2005 | 37 |
| Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility | Yen, HL; Herlocher, LM; Hoffmann, E; Matrosovich, MN; Monto, AS; Webster, RG; Govorkova, EA | 2005 | 31 |
| Detection and control of influenza outbreaks in well-vaccinated nursing home populations | Monto, AS; Rotthoff, J; Teich, E; Herlocher, ML; Truscon, R; Yen, HL; Elias, S; Ohmit, SE | 2004 | 43 |
| Influenza viruses resistant to the antiviral drug oseltamivir: Transmission studies in ferrets | Herlocher, ML; Truscon, R; Elias, S; Yen, HL; Roberts, NA; Ohmit, SE; Monto, AS | 2004 | 27 |
 | Workshop 1: Surveillance issues of pandemic influenza | Hannoun, C; Arden, N; Haaheim, L; Hampson, AW; Monto, AS; Nerome, K; Regnery, H; Ruben, FL; Shortridge, KF; Zimmerman, H | 1997 | 308 |
|
